Lead toxicity causes paralysis and pain in the extremities due to effects on demyelinization, axonal degeneration, and presynaptic block. Lead toxicity commonly affects sensory, visual, auditory, and cerebellar (coordination) functions, reflecting its impact on the nervous system. Normocytic, sideroblastic anemia is the consequence of lead’s inhibiting effects on enzymes in the heme biosynthesis pathway. Other clinical signs associated with lead toxicity are kidney damage, epigastric pain and nausea, and male and female reproductive failure. Hyperactivity, anorexia, decreased play activity, low intelligence quotient and poor school performance have been observed in children with high lead levels. Sources of lead include lead pipes, painted toys, some red lipsticks, lead paint or its dust, soil around old cars, old homes, or highways (past leaded gasoline contamination). Whole blood is concentrated about 75-fold greater than that of serum or plasma and it has the highest correlation with toxicity. For this reason, whole blood lead is defined by the CDC as the preferred test for detecting lead exposure. The World Health Organization has defined high whole-blood lead levels as > 20 μg/dL in adults and > 10 μg/dL in children. As of 2007, the CDC acceptable level of whole blood lead was 10 μg/dL. Some have proposed to lower reference values for whole blood lead. Associated Symptoms and Diseases: Microcytic hypochromic anemia, renal dysfunction, hypertension, anorexia, muscle discomfort, constipation, metallic taste, low IQ (children) Sources: Certain supplements, paint, contaminated soils (and plants grown in them), plumbing Protective Measures: Alpha lipoic acidprotection against toxicity, iron (reduces intestinal absorption Chelating Agents: Ca –EDTA

The Left Circumflex (LCX) artery is an essential component of the heart's arterial system, and its assessment in a Coronary Calcium Scan provides significant insights into cardiovascular health. The LCX branches off from the left coronary artery and encircles the heart muscle, primarily supplying blood to the lateral and posterior walls of the left ventricle. In the context of a Coronary Calcium Scan, which employs computed tomography (CT) to detect calcifications in the coronary arteries, the LCX is meticulously examined for signs of atherosclerotic plaque. Calcification in the LCX, like in other coronary arteries, indicates the presence of coronary artery disease (CAD), wherein calcium is a component of the plaque that can narrow or obstruct the arteries. The degree of calcification within the LCX is quantified to produce a calcium score, which is instrumental in evaluating the risk of future cardiovascular events. Notably, the presence of calcification in the LCX, particularly when combined with calcification in other coronary arteries, can significantly elevate the risk of myocardial infarction (heart attack) and other cardiac complications. The calcium score of the LCX, therefore, plays a critical role in cardiovascular risk assessment, guiding medical professionals in the management and treatment of individuals with potential heart disease. However, it's crucial to understand that a Coronary Calcium Scan, including the assessment of the LCX, provides an indication of plaque burden but does not directly measure the functional severity of arterial blockages. Thus, the scan is a preventive tool, aiding in the early detection of CAD and facilitating timely interventions such as lifestyle changes and pharmacotherapy to improve cardiovascular outcomes.

Left Main (LM)
CT Scan

In a Coronary Calcium Scan, the Left Main (LM) coronary artery represents a critical focus of assessment due to its primary role in the heart's blood supply. The LM artery is a short but crucial vessel that branches from the aorta and bifurcates into the Left Anterior Descending (LAD) and the Left Circumflex (LCX) arteries, supplying a significant portion of the heart muscle with oxygen-rich blood. During the scan, which employs computed tomography (CT) technology, the LM is evaluated for the presence of calcification – a key indicator of coronary artery disease (CAD). Calcifications in the LM are particularly concerning because of the artery's strategic location and the extensive area of myocardium it supplies. The calcification in the LM is quantified, contributing to the overall coronary calcium score, which is used to gauge the risk of future cardiac events. A high calcium score in the LM is a significant red flag, indicating a higher risk of severe cardiac events, such as myocardial infarction. This is primarily due to the potential for a large portion of the heart's blood supply to be compromised if the LM is obstructed. It's important to note, however, that while the Coronary Calcium Scan is effective in detecting the extent of calcified plaque, it does not assess the functional severity of any blockage or the presence of non-calcified, potentially vulnerable plaque. The identification of calcification in the LM artery on a Coronary Calcium Scan is therefore crucial for early intervention and management, guiding healthcare professionals in implementing preventive measures, including lifestyle modifications and pharmacological treatments, to mitigate the risk of heart disease and improve patient outcomes.